1. Home
  2. MESO vs PCT Comparison

MESO vs PCT Comparison

Compare MESO & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$18.63

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$9.04

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
PCT
Founded
2004
2015
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MESO
PCT
Price
$18.63
$9.04
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$24.00
$13.67
AVG Volume (30 Days)
218.4K
3.7M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,198,000.00
$5,660,000.00
Revenue This Year
$576.59
N/A
Revenue Next Year
$41.15
$723.85
P/E Ratio
N/A
N/A
Revenue Growth
191.39
N/A
52 Week Low
$9.61
$5.40
52 Week High
$21.00
$17.37

Technical Indicators

Market Signals
Indicator
MESO
PCT
Relative Strength Index (RSI) 56.49 49.60
Support Level $17.90 $8.34
Resistance Level $18.73 $9.48
Average True Range (ATR) 0.51 0.48
MACD -0.14 0.11
Stochastic Oscillator 43.00 78.31

Price Performance

Historical Comparison
MESO
PCT

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: